SOURCE: TriMarkPublications.com

TriMarkPublications.com

March 30, 2016 18:57 ET

Global Flow Cytometry Market Is Projected to Grow to $5.9 Billion in 2020

NEW YORK, NY--(Marketwired - March 30, 2016) - TriMarkPublications.com cites in its newly published "Global Flow Cytometry Markets" report that the global flow cytometry market is one of the fastest growing segments of the Life Science Markets, projected to grow at an analyzed rate of 12% to $5.9 billion in 2020. For more information, visit: https://www.trimarkpublications.com/products/global-flow-cytometry-markets/.

This report is an overview of the global flow cytometry market. The global flow cytometry market is one the fastest growing segments of the Life Sciences and Clinical Diagnostics Markets, projected to grow at an annualized rate of 12% to $5.9 billion in 2020. This TriMark Publications report provides an analysis of the global flow cytometry market, including size, growth, technology platforms, applications, new instrumentation, industry trends, companies participating in this market and the internal structure of the sector. In the current life science research, biopharmaceutical and clinical diagnostics markets, flow cytometry offers some of the brightest promise for growth and innovations.

Highly attractive growth areas covered in the study include:

  • Stem cell research.
  • Immunotherapy for cancer treatment.
  • Biomarkers and companion diagnostics.
  • Point of care flow cytometry for CD4 testing.
  • High throughput screening.
  • Immunology and vaccine development.

In this report, the reader will find detailed market analysis and forecasts through 2020 for the global flow cytometry market in North America, Western Europe, Asia-Pacific, the high growth emerging countries (Brazil, India and China) and resource-limited countries. For each region, the research, pharmaceutical and clinical diagnostics market segments are analyzed. Competitors are analyzed in detail.

Of particular interest in this report is the chapter, "The Point of Care Flow Cytometry Market." The global situation for HIV/AIDS ART and CD4 testing is analyzed in depth. It provides a detailed market forecast for flow cytometry and point of care (POC) flow cytometry, market analysis with table and charts, discussion of key participants, demand drivers, innovative new technologies in the pipeline and recent industry developments.

The rapidly growing field of biomarkers and companion diagnostics are analyzed from the perspective of reference laboratories offering prognostic and predictive biomarker assays with issues of validation discussed. Identification and discussion of drivers and restrictors for adoption of this technology by the pharmaceutical industry are presented.

This report includes the following features:

  • Five-year flow cytometry revenue projections by region -- North America, Western Europe, Asia-Pacific, emerging high growth countries, and resource-limited countries.
  • Five-year reagent, instrument and software revenue projections.
  • Review of current instrumentation technologies and a feature comparison of leading systems.
  • Market share of leading flow cytometry reagent and instrument suppliers.
  • Review of current and emerging flow cytometry technologies and their potential market applications.
  • Product development opportunities for new instruments, reagents and auxiliary products.
  • Profiles of current and emerging suppliers, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and corporate strategies.
  • Business opportunities and strategic recommendations for suppliers.
  • Review of current and emerging technologies and their market applications.
  • Product development opportunities for new instruments, reagents and consumables.

Key questions answered in this analysis include:

  • What is the current state of the flow cytometry market?
  • What are the main types of flow cytometry technologies currently available?
  • Who are the key players in this marketplace?
  • What are the barriers to entry for the flow cytometry market?
  • Which companies are utilizing cutting-edge technologies to develop, validate and market flow cytometry?
  • What are the current and projected flow cytometry market sizes in North America, Western Europe, Asia-Pacific, high growth emerging countries, and resource-limited countries?
  • What are the drivers and restrictors influencing the flow cytometry market?
  • Which flow cytometry application areas have the greatest potential for growth?
  • What are the near-term business opportunities in the flow cytometry market?
  • What are the development trends in flow cytometry?
  • Where are the new market growth areas in flow cytometry instruments and reagents?
  • How are complementary technologies blending with flow cytometry?
  • What are the main business strategies adopted by leading flow cytometry companies?
  • Who holds the proprietary rights to the flow cytometry market technology platforms?
  • How is this technology currently being applied and utilized?
  • What regulatory processes apply to flow cytometry testing technologies.
  • Which alliances show the greatest synergy in bringing flow cytometry to market?
  • Which shared technologies are driving the most encouraging development?
  • What are the business issues that go into justifying flow cytometry?

The emphasis in this analysis is on those companies who are actively developing and marketing flow cytometry instruments and reagents for life sciences research, pharmaceutical drug discovery and development, and clinical diagnostics. This study examines the flow cytometry instrument and reagents industry in the U.S., Western Europe, Asia-Pacific, high growth emerging countries, and resource-limited countries. These regional markets and their differences are examined in terms of investment in life sciences research, pharmaceutical drug development, and clinical diagnostics. Particular attention is paid to those regions in which the flow cytometry market is showing the greatest growth or most innovation.

 Major Conclusions:

• Global Flow Cytometry Market Projected to Reach $5.9 Billion by 2020.

• Three Major Companies Command Over Half the Global Flow Cytometry Market.

• Reagents and Consumables are the Fastest Growing Product Group.

• Flow Cytometry will Advance Research and Development of New Cellular Therapies, Biologicas and Vaccines.

• There is an Urgent Need for Point of Care Flow Cytometry in Resource Limited Countries.

Detailed charts with sales forecasts and marketshare data are included. For more information, visit: https://www.trimarkpublications.com/products/global-flow-cytometry-markets/.

About TriMarkPublications.com

TriMarkPublications.com is a global leader in the biotechnology, healthcare and life sciences market research publishing. For more information, please visit https://www.trimarkpublications.com.

Important Notice

The statements contained in this news release that are forward-looking are based on current expectations that are subject to a number of uncertainties and risks, and actual results may differ materially.

Attachment Available: http://www.marketwire.com/library/MwGo/2016/3/30/11G090260/Global_Flow_Cytometry_Sample-593a7fa31b29a03e95dbb1d7187f40ed.pdf

Contact Information